You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.

Revamping Alzheimer's Disease Diagnostics: Evaluating Future IVD Plasma p-Tau 181 and ApoE4 Immunoassays for Amyloid Detection in a Multi-Center Study Reflective of Routine Clinical Practice

This poster describes the most recent data regarding clinical performance of blood-based biomarkers pTau181 and ApoE4 in a multi center study reflecive of routine clinical practice.

Request medical material

Would you like to receive this poster via email to view later?

Browse more content from this congress

View additional content from this congress. Use the filters to refine your search.
Disease Area
Molecule

Please validate reCAPTCHA.

Request received

Thank you! Please check your email to view the asset(s) you requested.
Continue browsing